186 related articles for article (PubMed ID: 15641773)
1. CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.
De Guzman RN; Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2005 Jan; 44(2):490-7. PubMed ID: 15641773
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
[TBL] [Abstract][Full Text] [Related]
3. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977
[TBL] [Abstract][Full Text] [Related]
6. A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies.
Lin CH; Hare BJ; Wagner G; Harrison SC; Maniatis T; Fraenkel E
Mol Cell; 2001 Sep; 8(3):581-90. PubMed ID: 11583620
[TBL] [Abstract][Full Text] [Related]
7. Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB-binding protein.
Demarest SJ; Deechongkit S; Dyson HJ; Evans RM; Wright PE
Protein Sci; 2004 Jan; 13(1):203-10. PubMed ID: 14691235
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activator-coactivator recognition: nascent folding of a kinase-inducible transactivation domain predicts its structure on coactivator binding.
Hua QX; Jia WH; Bullock BP; Habener JF; Weiss MA
Biochemistry; 1998 Apr; 37(17):5858-66. PubMed ID: 9558319
[TBL] [Abstract][Full Text] [Related]
9. Acetyltransferase machinery conserved in p300/CBP-family proteins.
Yuan LW; Giordano A
Oncogene; 2002 Mar; 21(14):2253-60. PubMed ID: 11948408
[TBL] [Abstract][Full Text] [Related]
10. ZZ domain of CBP: an unusual zinc finger fold in a protein interaction module.
Legge GB; Martinez-Yamout MA; Hambly DM; Trinh T; Lee BM; Dyson HJ; Wright PE
J Mol Biol; 2004 Oct; 343(4):1081-93. PubMed ID: 15476823
[TBL] [Abstract][Full Text] [Related]
11. Three conformational states of the p300 CH1 domain define its functional properties.
Dial R; Sun ZY; Freedman SJ
Biochemistry; 2003 Aug; 42(33):9937-45. PubMed ID: 12924942
[TBL] [Abstract][Full Text] [Related]
12. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Taz2 domain of p300: insights into ligand binding.
Miller M; Dauter Z; Cherry S; Tropea JE; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1301-8. PubMed ID: 19966416
[TBL] [Abstract][Full Text] [Related]
14. A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP.
Matsuda S; Harries JC; Viskaduraki M; Troke PJ; Kindle KB; Ryan C; Heery DM
J Biol Chem; 2004 Apr; 279(14):14055-64. PubMed ID: 14722092
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.
Freedman SJ; Sun ZY; Poy F; Kung AL; Livingston DM; Wagner G; Eck MJ
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5367-72. PubMed ID: 11959990
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
19. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
[TBL] [Abstract][Full Text] [Related]
20. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
Kasper LH; Boussouar F; Ney PA; Jackson CW; Rehg J; van Deursen JM; Brindle PK
Nature; 2002 Oct; 419(6908):738-43. PubMed ID: 12384703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
